We hypothesize that HDAC6 could be a part of CoREST and other transcriptional repressor complexes in other cancers as well where inhibiting both LSD1 and HDAC6 can lead to comprehensive inhibition of the transcription complex leading to synergistic anti-cancer activity. The gene discussed is HDAC6; the disease is cancer.